See more : Queensland Gold Hills Corp. (OZAU.V) Income Statement Analysis – Financial Results
Complete financial analysis of Indiva Limited (NDVAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indiva Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Tishman Speyer Innovation Corp. II (TSIBU) Income Statement Analysis – Financial Results
- Aspira Women’s Health Inc. (AWH) Income Statement Analysis – Financial Results
- DiamondHead Holdings Corp. (DHHCW) Income Statement Analysis – Financial Results
- Forest Road Acquisition Corp. II (FRXB-WT) Income Statement Analysis – Financial Results
- Samhällsbyggnadsbolaget i Norden AB (publ) (SBB-B.ST) Income Statement Analysis – Financial Results
Indiva Limited (NDVAF)
About Indiva Limited
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.57M | 34.40M | 32.47M | 14.65M | 923.86K | 58.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.35K | 29.13K | 17.41K | 38.32K | 69.96K | 121.59K | 65.59K |
| Cost of Revenue | 27.05M | 26.25M | 25.40M | 15.52M | 869.50K | 43.14K | 188.37K | 1.16K | 4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.82K | 17.96K | 6.29K | 25.29K | 52.57K | 70.58K | 48.65K |
| Gross Profit | 10.52M | 8.15M | 7.07M | -873.55K | 54.36K | 15.16K | -188.37K | -1.16K | -4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.53K | 11.17K | 11.12K | 13.03K | 17.39K | 51.01K | 16.94K |
| Gross Profit Ratio | 28.00% | 23.70% | 21.76% | -5.96% | 5.88% | 26.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 32.26% | 38.35% | 63.89% | 34.01% | 24.86% | 41.95% | 25.82% |
| Research & Development | 877.01K | 1.02M | 416.96K | 11.64K | 122.59K | 24.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.01M | 6.29M | 6.56M | 5.86M | 6.92M | 6.74M | 2.06M | 889.99K | 219.93K | 918.44K | 83.36K | 81.67K | 110.20K | 205.35K | 116.63K | 178.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 5.35M | 6.53M | 4.94M | 1.61M | 2.16M | 605.46K | 364.92K | 222.57K | 34.97K | 57.25K | 0.00 | 1.02K | 848.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.37M | 12.82M | 11.50M | 7.47M | 9.08M | 7.35M | 2.42M | 1.11M | 254.90K | 975.69K | 83.36K | 82.69K | 111.04K | 205.35K | 116.63K | 178.84K | 379.13K | 356.69K | 168.15K | 334.90K | 165.46K | 167.19K | 178.89K |
| Other Expenses | 402.92K | 413.50K | 1.59M | 3.18M | 953.44K | 0.00 | -2.33K | -8.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.42K | 0.00 | -846.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.65M | 14.25M | 13.51M | 10.66M | 10.15M | 7.75M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 386.42K | 361.96K | 175.49K | 345.38K | 176.72K | 172.80K | 180.65K |
| Cost & Expenses | 39.70M | 40.50M | 38.91M | 26.18M | 11.02M | 7.71M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 402.24K | 379.92K | 181.78K | 370.67K | 229.29K | 243.38K | 229.30K |
| Interest Income | 0.00 | 36.13K | 217.69K | 7.00 | 137.33K | 112.88K | 29.65K | 0.00 | 0.00 | 1.57K | 0.00 | 0.00 | 1.27K | 44.00 | 92.00 | 5.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.91M | 4.45M | 2.93M | 2.02M | 439.54K | 1.16M | 248.65K | 0.00 | 0.00 | 14.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.24K | 0.00 | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Depreciation & Amortization | 393.33K | 410.48K | 484.93K | 386.93K | 862.85K | 407.09K | 188.37K | 29.84K | 4.01K | 906.00 | -166.72K | -165.37K | -222.09K | -378.92K | 126.00 | 240.00 | 7.29K | 5.27K | 7.34K | 10.49K | 11.27K | 5.61K | 1.76K |
| EBITDA | 272.34K | -5.89M | -11.04M | -11.03M | -10.10M | -7.13M | -948.25K | -1.10M | -235.46K | -974.12K | -83.36K | -82.69K | -111.04K | 1.03M | 453.30K | 1.78M | -371.60K | -345.52K | -157.03K | -321.87K | -148.07K | -116.19K | -161.95K |
| EBITDA Ratio | 0.72% | -17.13% | -34.00% | -75.27% | -1,027.15% | -12,230.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,591.41% | -1,186.15% | -902.10% | -840.03% | -211.65% | -95.56% | -246.91% |
| Operating Income | -2.13M | -6.10M | -6.44M | -8.74M | -10.10M | -7.54M | -1.14M | -1.13M | 258.91K | 971.22K | 83.36K | 82.69K | 111.04K | 1.41M | 686.69K | 2.18M | -378.89K | 350.79K | 164.37K | 332.35K | 159.33K | 121.80K | 163.71K |
| Operating Income Ratio | -5.66% | -17.73% | -19.84% | -59.68% | -1,092.91% | -12,928.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,622.64% | 1,204.26% | 944.28% | 867.40% | 227.75% | 100.18% | 249.59% |
| Total Other Income/Expenses | -2.79M | -4.95M | -9.94M | -6.54M | -1.30M | -1.01M | -475.68K | -59.36K | -11.49K | -2.12M | -166.72K | -165.37K | -220.82K | -1.23M | -569.93K | -2.81M | 0.00 | -350.79K | -164.37K | -332.35K | -159.33K | -121.80K | -163.71K |
| Income Before Tax | -4.92M | -11.05M | -15.28M | -15.42M | -11.40M | -8.66M | -4.60M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | 178.00K | 116.76K | -622.24K | 0.00 | 0.00 | 0.00 | 0.00 | 191.35K | 147.83K | 0.00 |
| Income Before Tax Ratio | -13.09% | -32.12% | -47.05% | -105.26% | -1,233.72% | -14,845.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 273.51% | 121.58% | 0.00% |
| Income Tax Expense | 0.00 | -118.30K | -266.95K | 1.06K | 46.87K | -129.46K | -47.96K | 20.93K | 508.69K | 14.00K | 0.00 | 0.00 | 220.82K | 1.61M | 570.29K | 2.02M | 40.15K | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Net Income | -4.92M | -10.93M | -15.01M | -15.42M | -11.44M | -8.53M | -4.55M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | -1.43M | -687.05K | -3.04M | -419.03K | -377.34K | -192.59K | -396.70K | -170.27K | -96.45K | -169.57K |
| Net Income Ratio | -13.09% | -31.78% | -46.22% | -105.27% | -1,238.80% | -14,623.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,794.57% | -1,295.41% | -1,106.39% | -1,035.33% | -243.37% | -79.33% | -258.53% |
| EPS | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| EPS Diluted | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| Weighted Avg Shares Out | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 37.28M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
| Weighted Avg Shares Out (Dil) | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 38.44M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
INDIVA TO REPORT SECOND QUARTER RESULTS PRE-MARKET ON TUESDAY, AUGUST 16, 2022
LONDON, ON , Aug. 8, 2022 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the quarter ended June 30, 2022...
Indiva Limited (NDVAF) CEO Carmine Marotta on Q1 2022 Results - Earnings Call Transcript
Indiva Limited (OTCQX:NDVAF) Q1 2022 Earnings Conference Call May 19, 2022 8:30 AM ET Company Participants Carmine Marotta - CEO Jennifer Welsh - CFO Conference Call Participants Andrew Semple - Echelon Capital Markets Michael Freeman - Raymond James Operator Good...
Indiva's (NDVAF) CEO Niel Marotta on Q4 2021 Results - Earnings Call Transcript
Indiva Limited ( OTCQX:NDVAF ) Q4 2021 Earnings Conference Call April 26, 2022 8:30 AM ET Company Participants Niel Marotta – Chief Executive Officer Jennifer Welsh – Chief Financial Officer Conference Call Participants Andrew Semple – Echelon Capital Michael Freeman...
Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)
Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)
Oregon's Grön's Edibles Producer Enters Into Deal With Indiva Limited Of Canada
Canadian cannabis edibles producer Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) will launch Grön products in Canada. The London, Ontario-based company confirmed Wednesday it has entered into a licensing and manufacturing agreement with Oregon-based Grön to bring its edibles to Canada.
Indiva Limited Sees 143% YoY Spike In Q3 Revenue, Maintains Leading Market Share In Edibles Category
Canadian producer of cannabis edibles Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) announced its financial and operating results Tuesday for the third quarter of fiscal 2021 ended September 30, revealing CA$8.3 million in gross revenue, up by 143% year-over-year. Year-to-date, gross revenue spiked 194%...
Indiva Limited (NDVAF) CEO Niel Marotta on Q3 2021 Results - Earnings Call Transcript
Indiva Limited (NDVAF) CEO Niel Marotta on Q3 2021 Results - Earnings Call Transcript
Indiva to Report Third Quarter Results Pre-market on Tuesday November 16th
LONDON, ON, Nov. 8, 2021 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, will report its three and nine month results for the period ended...
This Canadian Cannabis Company Experienced a Substantial Climb in Net Revenue and Became a Top 10 LP from the Edible Boom
In the world of cannabis, edibles are having a moment. From beverages to gummies, tinctures to chocolates, mints, and more, new brands are popping up each quarter and edible sales are on the rise.
Indiva's Shares Jump On Additional $8.5M Investment From Sundial
Cannabis edibles producer Indiva Limited (TSXV:NDVA) (OTCQX: NDVAF) confirmed Tuesday that it has received an additional $8.5 million in available funds from Canadian cannabis company Sundial Growers Inc. (NASDAQ: SNDL). The two companies amended the terms of their existing non-revolving term loan facility bringing the total principal amount...
Source: https://incomestatements.info
Category: Stock Reports